close
close

Guiltandivy

Source for News

Donald Glover cancels Childish Gambino's remaining tour dates due to health concerns
Update Information

Donald Glover cancels Childish Gambino's remaining tour dates due to health concerns

The multi-hyphenate Donald Glover announced on social media Friday that he was canceling Childish Gambino's remaining tour dates due to health concerns.

In a post on

“After assessment, it became clear that I would not be performing that evening, and after further testing, I was unable to complete the remainder of the U.S. tour in the required time,” he wrote. “At the moment I have surgery planned and I need some time off to heal.”

The news comes a month after Glover shared in a post on X that he had to postpone the tour to “focus” on his physical health.

Glover did not provide any further information regarding his specific health concerns in his statement Friday. A Glover spokesman did not immediately respond to a request for comment.

The Grammy Award-winning “This Is America” ​​singer called the decision to cancel tour dates in North America, the United Kingdom and Europe “difficult.” But he wrote: “My road to recovery is something I need to seriously address.”

All tickets will be refunded, he said.

Fans were surprised and excited to see Childish Gambino back on stage after Glover announced a new tour in May.

Glover, who worked on the creation of “Mr. & Mrs. Smith” series reboot for Amazon Prime had previously said that his 2018 tour would be “the final Childish Gambino tour ever.”

In May, Glover released the album Atavista, a reworked version of his 2020 project 3.15.20. He then announced the tour starting in August called “The New World Tour”. “Bando Stone & the New World,” his final Childish Gambino album, was released in July.

Glover has several other upcoming projects in the works, including Peacock's “Community: The Movie” and “Mufasa: The Lion King.”

In his post on Friday, the artist called for “love, privacy and support” as he focuses on his health.

LEAVE A RESPONSE

Your email address will not be published. Required fields are marked *